Ropivacaine 7.5 mg/ml for elective Caesarean section. A clinical and pharmacokinetic comparison of 150 mg and 187.5 mg

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 9, 1997, Pages 1149-1156

  Irestedt, L ^a   Emanuelsson, B M ^b   Ekblom, A ^b   Olofsson, C ^a   Reventlid, H ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Research and Development at Scania Technical Centre   (Sweden)

Author keywords

Anesthetic quality; Elective cesarean section; Epidural anesthesia; Long acting amide local anesthetics; Neonatal evaluation; Pharmacokinetics; Ropivacaine

Indexed keywords

ROPIVACAINE;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPIDURAL ANESTHESIA; FEMALE; HUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0030698820     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04857.x     Document Type: Article

References (26)

1. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979: 51: 285-287.
2. King MJ, Bowden MI, Cooper GM. Epidural fentanyl and 0.5% bupivacaine for elective section. Anaesthesia 1990: 45: 285-288.
3. Paech MJ, Westmore MD, Speirs HM. A double-blind comparison of epidural bupivacaine and bupivacaine-fentanyl for caesarean section. Anaesth Intensive Care 1990: 18: 22-30.
4. Olofsson C, Ekblom A, Sköldefors E, Wåglund B, Irestedt L. Anesthetic quality during cesarean section following subarachnoid or epidural administration of bupivacaine with or without fentanyl. Acta Anaesthesiol Scand 1997: 3: 332-338.
5. Griffin RP, Reynolds F. Extradural anaesthesia for Caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth 1995: 74: 512-516.
6. Datta S, Camann W, Bader A, VanderBurgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology 1995: 82: 1346-1352.
7. Ekblom A, Hansson P. Pain intensity measurements in patients with acute pain receiving afferent stimulation. J Neurol Neurosurg Psychiatry 1988: 51: 481-486.
8. Amiel-Tison C, Barrier B, Shnider SM, Levinson G, Hugher SC, Stefani SJ. A new neurologic and adaptive capacity scoring system for evaluating obstetric medications in full-term new-borns. Anesthesiology 1982: 56: 340-350.
9. Björk M, Pettersson KJ, Österlöf G. Capillary gas chromatographic method for the simultaneous determination of local anaesthetics in plasma samples. J Chromatogr Biomed Appl 1990: 553: 229-234.
10. Arvidsson T, Eklund E. Determination of free concentration of ropivacaine and bupivacaine in blood plasma by ultrafiltration and coupled-column liquid chromatography. J Chromatogr B Biomed Appl 1995: 668: 91-98.
11. Russel IF. Levels of anaesthesia and intraoperative pain at caesarean section under regional block. Int J Obstet Anesth 1995: 4: 71-77.
12. Craft JB, Roizen MF, Dao SD et al. A comparison of T4 and T7 dermatomal levels of analgesia for caesarean section using the lumbar epidural technique. Can Anaesth Soc J 1982: 29: 264-269.
13. Jackson R, Reid JA, Thorburn J. Volume preloading is not essential to prevent spinal-induced hypotension at Caesarean section. Br J Anaesth 1995: 75: 262-265.
14. Rout CC, Akoojee SS, Rocke DA, Gouws E. Rapid administration of crystalloid preload does not decrease the incidence of hypotension after spinal anaesthesia for Caesarean section. Br J Anaesth 1992: 68: 394-397.
15. Rout CC, Rocke DA, Levin J, Gouws E, Reddy D. A re-evaluation of the role of crystalloid preload in the prevention of hypotension associated with spinal anesthesia for elective cesarean section. Anesthesiology 1993: 79: 262-269.
16. Wennberg E, Frid I, Haljamäe H, Wennergren M, Kjellmer I. Comparison of Ringer's acetate with 3% dextran 70 for volume loading before extradural caesarean section. Br J Anaesth 1990: 65: 654-660.
17. Berg EM, Fasting S, Sellevold OF. Serious complications with dextran-70 despite hapten prophylaxis. Is it best avoided prior to delivery? Anaesthesia 1991: 46: 1033-1035.
18. Kuhnert BR, Kennard MJ, Linn PL. Neonatal neurobehavior after epidural anesthesia for cesarean section: a comparison of bupivacaine and chloroprocaine. Anesth Analg 1988: 67: 64-68.
19. Jani K, McEvedy B, Harris S, Miller S. Neonatal outcome after spinal or epidural bupivacaine 0.5% for elective caesarean section. In: Reynolds F, ed. Epidural and spinal blockade in obstetrics. London: Baillière Tindall, 1990: 229-231.
20. Lee A, Fagan D, Lamont M, Tucker GT, Halldin M, Scott DB. Disposition kinetics of ropivacaine in humans. Anesth Analg 1989: 69: 736-738.
21. Santos AC, Pedersen H, Sallusto JA et al. Pharmacokinetics of ropivacaine in nonpregnant and pregnant ewes. Anesth Analg 1990: 70: 262-266.
22. Morrison LMM, Emanuelsson B-M, McClure JH et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine. Br J Anaesth 1994: 72: 164-169.
23. Irestedt L, Lagercrantz H, Hjemdahl P, Hägnevik K, Belfrage P. Fetal and maternal plasma catecholeamine levels at elective cesarean section under general or epidural anesthesia versus vaginal delivery. Am J Obstet Gynecol 1982: 142: 1004-1010.
24. Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokin 1990: 18: 20-36.
25. Knudsen K, Beckman-Suurküla M, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects during i.v. infusions of ropivacaine, bupivacaine, and placebo in volunteers. Br J Anaesth 1997 (in press).
26. Belfrage P, Raabe N, Thalme B, Berlin A. Lumbar epidural analgesia with bupivacaine in labor. Ant J Obstet Gynecol 1975: 121: 360-365.